Literature DB >> 34609560

miR profile in pagetic osteoclasts: from large-scale sequencing to gene expression study.

Hoang Dong Nguyen1, Martine Bisson2, Michelle Scott1, Gilles Boire2, Luigi Bouchard3, Sophie Roux4.   

Abstract

Paget's disease of bone (PDB) is characterized by excessive and disorganized bone remodeling, in which bone-resorbing osteoclasts play a key role. We investigated microRNA (miR) expression in osteoclasts derived from the blood of 40 PDB patients and 30 healthy controls. By deep sequencing, a preliminary analysis identified differentially expressed miRs in a discovery cohort of 9 PDB patients and 9 age and sex-matched healthy controls. Six mature miRs, miR-29b1-3p, miR-15b-5p, miR-181a-5p, let-7i-3p, miR-500b-5p, and miR-1246, were found to be significantly decreased in pagetic overactive osteoclasts. The differential expression of the miRs was confirmed by the analysis of a larger independent cohort using qPCR. In an integrative network biology analysis of the miR candidates, we identified strong validated interactions between the miRs and some pathways, primarily apoptosis, and major osteoclast signaling pathways including PI3K/Akt, IFNγ, or TGFβ, as well as c-Fos, a transcription factor, and MMP-9, a metalloprotease. In addition, other genes like CCND2, CCND1, WEE1, SAMHD1, and AXIN2 were revealed in this network of interactions. Our results enhance the understanding of osteoclast biology in PDB; our work may also provide fresh perspectives on the research or therapeutic development of other bone diseases. KEY MESSAGES: miR profile in overactive osteoclasts from patients with Paget's disease of bone. Six mature miRs were significantly decreased in pagetic osteoclasts vs controls. miRs of interest: let7i-3p, miR-15b-5p, -29b1-3p, -181a-5p, -500b-5p, and -1246. Target genes and enriched pathways highlight the importance of apoptotic pathways.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Gene expression; Osteoclast; Paget’s disease of bone; RNA-Seq; microRNAs

Mesh:

Substances:

Year:  2021        PMID: 34609560     DOI: 10.1007/s00109-021-02128-5

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  47 in total

Review 1.  Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals.

Authors:  Rudolf Jaenisch; Adrian Bird
Journal:  Nat Genet       Date:  2003-03       Impact factor: 38.330

2.  The majority of the genetic risk for Paget's disease of bone is explained by genetic variants close to the CSF1, OPTN, TM7SF4, and TNFRSF11A genes.

Authors:  Pui Yan Jenny Chung; Greet Beyens; Steven Boonen; Socrates Papapoulos; Piet Geusens; Marcel Karperien; Filip Vanhoenacker; Leon Verbruggen; Erik Fransen; Jan Van Offel; Stefan Goemaere; Hans-Georg Zmierczak; René Westhovens; Jean-Pierre Devogelaer; Wim Van Hul
Journal:  Hum Genet       Date:  2010-09-14       Impact factor: 4.132

Review 3.  Paget's disease of bone: evidence for complex pathogenetic interactions.

Authors:  Pui Yan Jenny Chung; Wim Van Hul
Journal:  Semin Arthritis Rheum       Date:  2011-09-29       Impact factor: 5.532

4.  Genome-wide association identifies three new susceptibility loci for Paget's disease of bone.

Authors:  Omar M E Albagha; Sachin E Wani; Micaela R Visconti; Nerea Alonso; Kirsteen Goodman; Maria Luisa Brandi; Tim Cundy; Pui Yan Jenny Chung; Rosemary Dargie; Jean-Pierre Devogelaer; Alberto Falchetti; William D Fraser; Luigi Gennari; Fernando Gianfrancesco; Michael J Hooper; Wim Van Hul; Gianluca Isaia; Geoff C Nicholson; Ranuccio Nuti; Socrates Papapoulos; Javier del Pino Montes; Thomas Ratajczak; Sarah L Rea; Domenico Rendina; Rogelio Gonzalez-Sarmiento; Marco Di Stefano; Lynley C Ward; John P Walsh; Stuart H Ralston
Journal:  Nat Genet       Date:  2011-05-29       Impact factor: 38.330

5.  Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone.

Authors:  Nancy Laurin; Jacques P Brown; Jean Morissette; Vincent Raymond
Journal:  Am J Hum Genet       Date:  2002-04-30       Impact factor: 11.025

6.  Enhanced RANK ligand expression and responsivity of bone marrow cells in Paget's disease of bone.

Authors:  C Menaa; S V Reddy; N Kurihara; H Maeda; D Anderson; T Cundy; J Cornish; F R Singer; J M Bruder; G D Roodman
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

Review 7.  Genetics and aetiology of Pagetic disorders of bone.

Authors:  Miep H Helfrich; Lynne J Hocking
Journal:  Arch Biochem Biophys       Date:  2008-03-10       Impact factor: 4.013

8.  The p62 P392L mutation linked to Paget's disease induces activation of human osteoclasts.

Authors:  Estelle Chamoux; Julie Couture; Martine Bisson; Jean Morissette; Jacques P Brown; Sophie Roux
Journal:  Mol Endocrinol       Date:  2009-07-09

9.  Autophagy and 3-Phosphoinositide-Dependent Kinase 1 (PDK1)-Related Kinome in Pagetic Osteoclasts.

Authors:  Stephen McManus; Martine Bisson; Richard Chamberland; Michèle Roy; Shekeba Nazari; Sophie Roux
Journal:  J Bone Miner Res       Date:  2016-07       Impact factor: 6.741

Review 10.  Pathobiology of Paget's Disease of Bone.

Authors:  Deborah L Galson; G David Roodman
Journal:  J Bone Metab       Date:  2014-05-31
View more
  1 in total

Review 1.  Update on the pathogenesis and genetics of Paget's disease of bone.

Authors:  Luigi Gennari; Domenico Rendina; Daniela Merlotti; Guido Cavati; Christian Mingiano; Roberta Cosso; Maria Materozzi; Filippo Pirrotta; Veronica Abate; Marco Calabrese; Alberto Falchetti
Journal:  Front Cell Dev Biol       Date:  2022-08-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.